AHPRA / TGA advertising review

NRS-071 · $1,400 · AUD, excluding GST

This is a service reference for discussing and agreeing the work with NRS. The title and fee come from the approved catalogue; the written engagement defines the deliverables and acceptance.

What to know

Ahpra rules for regulated health-service advertising and TGA rules for therapeutic goods can both apply. Prescription brand names, ingredients, classes and indirect references need contextual review. Renaming a medicine is not a compliance workaround.

Prepare for the conversation

Identify the industry, jurisdiction, people responsible, relevant systems and the material to review. Use approved, redacted examples and identify the primary regulatory sources.

Confirm the scope

Agree the exact obligations and workflows covered, evidence required, responsible reviewer and any need for independent legal or professional advice. Clinical governance and public advertising are related but separate questions.

Review and accept

Check that findings quote the material at issue, cite the applicable source and state what remains uncertain. Keep the decision, reviewer and reviewed version with the resulting policy or change.

Health and professional responsibilities

Keep personal or clinical records in the approved system. Regulatory assistance needs a responsible person to review the actual facts and current sources. Ahpra advertising guidance, TGA prescription advertising guidance and the Australian Privacy Principles are reference points; their applicability depends on the work. Read health advertising review and Abe’s role.

Next step

Discuss NRS-071 with Bec and Justin, or compare the other compliance, governance & safety services. View all 108 services.